<p>Changes of the serum concentration of substance P (SP) and SP drainage (SP dr) and the acute pain intensity NPS in time.</p
Background: The daily fluctuations of many physiologic and behavioral parameters are differentially ...
Substance P (SP) is a neuropeptide belonging to the family of tachykinins. It acts in the central ne...
<p>Expression is calculated as fold-change over control treatment, Saline (s.c.)/Saline (intralumina...
<p>The interaction between the serum concentration of substance P (SP) and the acute pain intensity ...
<p>Interaction between the serum concentration of substance P (SP) and the disease activity (DAS) an...
There is a limited information about the role of Substance P (SP) in acute pain nociception followin...
Evidence suggests that substance P (SP) is involved in chronic joint inflammation, such as the patho...
Pain is one of the most prevalent health conditions in the world. It is widely accepted that chronic...
Evidence suggests that substance P (SP) is involved in chronic joint inflammation, such as the patho...
Objective There is a limited information about the role of Substance P (SP) in acute pain nociceptio...
The aim. The primary aim of this study is to assess the variance in substance P concentration, takin...
<p>The relationship between NPS and the serum concentration of substance P (SP) for OA patients.</p
Substance P (SP), a neuropeptide and pain transmitter has multiple roles and is involved in various ...
Significant changes in serum cytokines according to sex and strain following LPS treatment.</p
Substance P (SP) is a highly conserved member of the tachykinin peptide family that is widely expres...
Background: The daily fluctuations of many physiologic and behavioral parameters are differentially ...
Substance P (SP) is a neuropeptide belonging to the family of tachykinins. It acts in the central ne...
<p>Expression is calculated as fold-change over control treatment, Saline (s.c.)/Saline (intralumina...
<p>The interaction between the serum concentration of substance P (SP) and the acute pain intensity ...
<p>Interaction between the serum concentration of substance P (SP) and the disease activity (DAS) an...
There is a limited information about the role of Substance P (SP) in acute pain nociception followin...
Evidence suggests that substance P (SP) is involved in chronic joint inflammation, such as the patho...
Pain is one of the most prevalent health conditions in the world. It is widely accepted that chronic...
Evidence suggests that substance P (SP) is involved in chronic joint inflammation, such as the patho...
Objective There is a limited information about the role of Substance P (SP) in acute pain nociceptio...
The aim. The primary aim of this study is to assess the variance in substance P concentration, takin...
<p>The relationship between NPS and the serum concentration of substance P (SP) for OA patients.</p
Substance P (SP), a neuropeptide and pain transmitter has multiple roles and is involved in various ...
Significant changes in serum cytokines according to sex and strain following LPS treatment.</p
Substance P (SP) is a highly conserved member of the tachykinin peptide family that is widely expres...
Background: The daily fluctuations of many physiologic and behavioral parameters are differentially ...
Substance P (SP) is a neuropeptide belonging to the family of tachykinins. It acts in the central ne...
<p>Expression is calculated as fold-change over control treatment, Saline (s.c.)/Saline (intralumina...
DOI
Add to ORKG